English NHS Failing To Meet Targets For Availability Of NICE-Approved Cancer Drugs
• By Leela Barham
Pink Sheet analysis shows that availability targets for cancer drugs approved under the UK’s Early Access to Medicines Scheme are routinely missed. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
